Pharmaceutical Manufacturing Market - Global Industry Analysis

The global Pharmaceutical Manufacturing market accrued earnings worth approximately 401.32(USD Billion) in 2020 and is predicted to gain revenue of about 832.11 (USD Billion) by 2028, is set to record a CAGR of nearly 11.32% over the period from 2021 to 2028. The report offers assessment and analysis of the Pharmaceutical Manufacturing market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Pharmaceutical Manufacturing Market: Overview

Pharmaceutical manufacturing is the method of industrial-scale synthesizing of pharma drugs and it is also a part & parcel of pharma sector. The procedure of drug production also termed as pharmaceutical manufacturing is divided into number of unit functions including milling, coating, granulation, and tablet pressing. Furthermore, pharma sector has undergone a humongous change with evolution of novel & cost-efficient techniques along with introducing new approaches in pharma manufacturing industry. Surge in funding of pharma manufacturing processes in pharmaceutical industry will translate into enlarged scope of pharmaceutical manufacturing industry in upcoming years. Apart from this, pharma production downtime & output of product wastage are minimized with execution of AI & robotic systems.

Pharmaceutical Manufacturing Market: Growth Drivers

Growing demand for paperless and smart functions in drug production will drive pharmaceutical manufacturing market trends. In addition to this, consistent growth in domain of personalized medicine has led to exploration & development of patient-centric models, thereby further creating new growth avenues for pharmaceutical manufacturing business. Apparently, altering landscape of small drugs in drug potency terms, medicine complexity, business makeup, and production trends is predicted to aid demand for small drugs in pharma sector. This, in turn, will prompt expansion of pharmaceutical manufacturing industry over forecast period.

Moreover, increase in medicine approvals by regulatory authorities such as the U.S. FDA is projected to boost drug manufacturing procedures, thereby completely transforming the phase of growth of pharmaceutical manufacturing industry. Additionally, a massive rise in funding of clinical experiments by pharma firms & surge in research activities on new drug development will steer growth of pharmaceutical manufacturing market.

Regional Landscape

North America To Contribute Majorly Towards Global Market Size By 2028

The expansion of pharmaceutical manufacturing industry in North America during 2021-2028 is due to huge number of strategic alliances between pharmaceutical firms in countries such as Canada and the U.S. In addition to this, rise in spending on prescribed medicines in the U.S. will spur regional market size within next couple of years. Apart from this, increase in number of research projects associated with drug efficiency testing activities in Canada and the U.S. will expedite regional market value in ensuing years.

Competitive Landscape

Key players profiled in report and leveraging industry landscape are Novartis AG, Pfizer, Inc., AstraZeneca, Merck & Co., Inc., Sanofi SA, Johnson & Johnson, Roche Holding AG, AbbVie, Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Novo Nordisk A/S, Takeda Pharmaceuticals, Inc., Gilead Sciences, Inc.,  and Bristol Myers Squibb Company.

The global Pharmaceutical Manufacturing Market is segmented as follows:

By Drug Type

• Biologics & Biosimilars
• Small Medicines

By Drug Development

• In-house  
• Outsourced

By Formulation

• Tablets
• Injectables
• Capsules
• Sprays
• Suspensions
• Powders

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Type
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
  • 2.2. Pharmaceutical Manufacturing Market: Snapshot
• Chapter 3. Global Pharmaceutical Manufacturing Market– Industry Analysis
  • 3.1. Pharmaceutical Manufacturing Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Escalating demand for paperless and smart operations in drug production will scale up pharmaceutical manufacturing market growth.
    • 3.2.2. Constant & seamless growth of personalized medicine market has led to exploration of patient-centric prototypes, thereby generating new growth opportunities for pharmaceutical manufacturing sector.
  • 3.3. Porter’s Five Forces Analysis
  • 3.4. Market Attractiveness Analysis
    • 3.4.1. Market attractiveness analysis By Drug Type
    • 3.4.2. Market attractiveness analysis By Drug Development
    • 3.4.3. Market attractiveness analysis By Formulation
• Chapter 4. Global Pharmaceutical Manufacturing Market– Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Pharmaceutical Manufacturing Market: company market share, 2019
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Pharmaceutical Manufacturing Market– Drug Type Analysis
  • 5.1. Global Pharmaceutical Manufacturing Market overview: By Drug Type
    • 5.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Type, 2020 and 2028
  • 5.2. Biulogics & Biosimilars
    • 5.2.1. Global Pharmaceutical Manufacturing Market by Biulogics & Biosimilars, 2018–2028(USD Billion)
  • 5.3. Small Medicines
    • 5.3.1. Global Pharmaceutical Manufacturing Market by Small Medicines, 2018–2028(USD Billion)
• Chapter 6. Global Pharmaceutical Manufacturing Market– Drug Development Analysis
  • 6.1. Global Pharmaceutical Manufacturing Market overview: By Drug Development
    • 6.1.1. Global Pharmaceutical Manufacturing Market share, By Drug Development, 2020 and 2028
  • 6.2. In-house
    • 6.2.1. Global Pharmaceutical Manufacturing Market by In-house , 2018–2028(USD Billion)
  • 6.3. Outsourced
    • 6.3.1. Global Pharmaceutical Manufacturing Market by Outsourced, 2018–2028(USD Billion)
• Chapter 7. Global Pharmaceutical Manufacturing Market– Formulation Analysis
  • 7.1. Global Pharmaceutical Manufacturing Market overview: By Formulation
    • 7.1.1. Global Pharmaceutical Manufacturing Market share, By Formulation, 2020 and 2028
  • 7.2. Tablets
    • 7.2.1. Global Pharmaceutical Manufacturing Market by Tablets , 2018–2028(USD Billion)
  • 7.3. Injectables
    • 7.3.1. Global Pharmaceutical Manufacturing Market by Injectables, 2018–2028(USD Billion)
  • 7.4. Capsules
    • 7.4.1. Global Pharmaceutical Manufacturing Market by Capsules, 2018–2028(USD Billion)
  • 7.5. Sprays
    • 7.5.1. Global Pharmaceutical Manufacturing Market by Sprays, 2018–2028(USD Billion)
  • 7.6. Suspensions
    • 7.6.1. Global Pharmaceutical Manufacturing Market by Suspensions, 2018–2028(USD Billion)
  • 7.7. Powders
    • 7.7.1. Global Pharmaceutical Manufacturing Market by Powders, 2018–2028(USD Billion)
• Chapter 8. Company Profiles
  • 8.1. Novartis AG
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategy
    • 8.1.5. Recent Developments
  • 8.2. Pfizer, Inc.
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategy
    • 8.2.5. Recent Developments
  • 8.3. AstraZeneca
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategy
    • 8.3.5. Recent Development
  • 8.4. Merck & Co., Inc.
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategy
    • 8.4.5. Recent Development
  • 8.5. Sanofi SA
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategy
    • 8.5.5. Recent Development
  • 8.6. Johnson & Johnson
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategy
    • 8.6.5. Recent Development
  • 8.7. Roche Hulding AG
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategy
    • 8.7.5. Recent Development
  • 8.8. AbbVie, Inc.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategy
    • 8.8.5. Recent Development
  • 8.9. Eli Lilly and Company
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategy
    • 8.9.5. Recent Development
  • 8.10. Sun Pharmaceutical Industries Limited
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Portfolio
    • 8.10.4. Business Strategy
    • 8.10.5. Recent Development
  • 8.11. Bristul Myers Squibb Company
    • 8.11.1. Overview
    • 8.11.2. Financials
    • 8.11.3. Product Portfolio
    • 8.11.4. Business Strategy
    • 8.11.5. Recent Development
  • 8.12. Gilead Sciences, Inc.
    • 8.12.1. Overview
    • 8.12.2. Financials
    • 8.12.3. Product Portfolio
    • 8.12.4. Business Strategy
    • 8.12.5. Recent Development
  • 8.13. Takeda Pharmaceuticals, Inc.
    • 8.13.1. Overview
    • 8.13.2. Financials
    • 8.13.3. Product Portfolio
    • 8.13.4. Business Strategy
    • 8.13.5. Recent Development
  • 8.14. Novo Nordisk A/S
    • 8.14.1. Overview
    • 8.14.2. Financials
    • 8.14.3. Product Portfolio
    • 8.14.4. Business Strategy
    • 8.14.5. Recent Development
  • 8.15. Cipla Limited
    • 8.15.1. Overview
    • 8.15.2. Financials
    • 8.15.3. Product Portfolio
    • 8.15.4. Business Strategy
    • 8.15.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Pharmaceutical Manufacturing Marketattractiveness, By Drug Type
6. Global Pharmaceutical Manufacturing Marketattractiveness, By Drug Development
7. Global Pharmaceutical Manufacturing Marketshare by Drug Type ,2020 and 2028 (USD Billion)
8. Global Pharmaceutical Manufacturing Marketby Biologics & Biosimilars, 2018–2028(USD Billion)
9. Global Pharmaceutical Manufacturing Marketby Small Medicines, 2018–2028(USD Billion)
10. Global Pharmaceutical Manufacturing Marketshare by Drug Development ,2020 and 2028 (USD Billion)
11. Global Pharmaceutical Manufacturing Marketby In-house , 2018–2028(USD Billion)
12. Global Pharmaceutical Manufacturing Marketby Outsourced, 2018–2028(USD Billion)
13. Global Pharmaceutical Manufacturing Marketshare by Formulation ,2020 and 2028 (USD Billion)
14. Global Pharmaceutical Manufacturing Marketby Tablets, 2018–2028(USD Billion)
15. Global Pharmaceutical Manufacturing Marketby Injectables, 2018–2028(USD Billion)
16. Global Pharmaceutical Manufacturing Marketby Capsules, 2018–2028(USD Billion)
17. Global Pharmaceutical Manufacturing Marketby Sprays, 2018–2028(USD Billion)
18. Global Pharmaceutical Manufacturing Marketby Suspensions, , 2018–2028(USD Billion)
19. Global Pharmaceutical Manufacturing Marketby Powders, 2018–2028(USD Billion)
20. Global Pharmaceutical Manufacturing Marketshare, by Region, 2020 and 2028
21. North America Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
22. Europe Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
23. Asia Pacific Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
24. Latin America Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
25. The Middle East and Africa Pharmaceutical Manufacturing Market, 2018–2028(USD Billion)
 

Table Of Tables

List of Tables

1. Global Pharmaceutical Manufacturing Market: snapshot
2. Drivers of the Pharmaceutical Manufacturing Market: impact analysis
3. North America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
4. North America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
5. North America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
6. The U.S. Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
7. The U.S. Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
8. The U.S. Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
9. Rest of North America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
10. Rest of North America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
11. Rest of North America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
12. Europe Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
13. Europe Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
14. Europe Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
15. UK Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
16. UK Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
17. UK Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
18. France Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
19. France Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
20. France Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
21. Germany Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
22. Germany Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
23. Germany Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
24. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
25. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
26. Rest of Europe Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
27. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
28. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
29. Asia Pacific Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
30. China Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
31. China Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
32. China Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
33. Japan Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
34. Japan Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
35. Japan Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
36. India Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
37. India Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
38. India Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
39. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
40. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
41. Rest of Asia Pacific Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
42. Latin America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
43. Latin America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
44. Latin America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
45. Brazil Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
46. Brazil Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
47. Brazil Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
48. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
49. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
50. Rest of Latin America Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
51. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
52. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
53. The Middle East and Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
54. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
55. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
56. Saudi Arabia Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
57. South Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
58. South Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
59. South Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Drug Type ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Drug Development ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Pharmaceutical Manufacturing Market revenue, By Formulation ,2018–2028(USD Billion)